Faculty
Genevieve Kanter
Associate Professor
Programs
Education
PhD in Economics and Sociology, University of Chicago
Expertise
Health economics
Health policy
FDA
Pharmaceuticals and medical devices
Conflicts of interest
Physician-industry relationships
Medical ethics
Biography
Genevieve P. Kanter, PhD, is Associate Professor of Public Policy at the USC Price School of Public Policy.
She is an economist whose research focuses on the economics of regulation, with applications to health care. She has conducted research on conflicts of interest in medicine, FDA advisory committees, and government ethics (e.g., revolving door, transparency). She also written about policies related to biomedical technologies, AI, and cybersecurity.
Professor Kanter’s research and essays have been published in leading academic journals, including JAMA, the New England Journal of Medicine, Health Affairs, and Milbank Quarterly, and her work and expert commentary have been featured in major media outlets, including the New York Times, Washington Post, Wall Street Journal, Reuters, AP, NPR, CNBC, Politico, the Atlantic, and STAT.
She serves on the Medicare Evidence Development and Coverage Advisory Committee (the federal advisory committee providing guidance on Medicare coverage of medical products) and is on the editorial board of BMC Medical Ethics. She is former Chair of the Advisory Board of the AcademyHealth Health Economics Interest Group.
Professor Kanter received a PhD in Economics and in Sociology from the University of Chicago; completed an NIH postdoctoral fellowship in health and demography at Princeton University; and completed research fellowships in health policy and ethics at Massachusetts General Hospital and Harvard University.
Selected Publications
- Kanter GP. Conflicts of interest in advisory committees – facts, fallacies, and the limits of reform. N Engl J Med 2026; 394:1150-1152.
URL: https://www.nejm.org/doi/abs/10.1056/NEJMp2514012 - Kanter GP, Mankowitz T, Lurie P. Conflicts of interest in federal vaccine advisory committees. JAMA 2025; 334:1295-1297.
URL: https://jamanetwork.com/journals/jama/fullarticle/2837784 - Mccoy, M. S., Gaines, M. E., Joffe, S., Kanter, G. P., Largent, E. A., Lo, B., Lynch, H. F., Whelan, A. M., & Mello, M. M. (2025). A framework for assessing the permissibility of academic leaders’ outside activities. The Milbank Quarterly.
In The News
Boston public radio's Curiosity Desk
Kanter featured for a segment about a new FDA policy on psychedelic drugs
Featured Faculty: Genevieve Kanter
Medscape.com
Kanter quoted about the trend of scientists fact-checking federal government officials
Featured Faculty: Genevieve Kanter
USC Price News
Why RFK Jr.’s firing of FDA experts likely won’t improve public trust
Featured Faculty: Genevieve Kanter
Affiliated Research Centers
Schaeffer Institute for Public Policy & Government Service
Kudos
March 24, 2026 Genevieve Kanter, Associate Professor; Kanter’s work on FDA advisory committees is cited in a GAO report: FDA Advisory Committees: More Transparency Needed on Policies for Making Conflict of Interest Determinations